Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

131 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Commonalities and differences in set-up and data collection across European spondyloarthritis registries - results from the EuroSpA collaboration.
Linde L, Ørnbjerg LM, Rasmussen SH, Love TJ, Loft AG, Závada J, Vencovský J, Laas K, Nordstrom D, Sokka-Isler T, Gudbjornsson B, Gröndal G, Iannone F, Ramonda R, Hellamand P, Kristianslund EK, Kvien TK, Rodrigues AM, Santos MJ, Codreanu C, Rotar Z, Tomšič M, Castrejon I, Díaz-Gonzáles F, Di Giuseppe D, Ljung L, Nissen MJ, Ciurea A, Macfarlane GJ, Heddle M, Glintborg B, Østergaard M, Hetland ML. Linde L, et al. Among authors: castrejon i. Arthritis Res Ther. 2023 Oct 19;25(1):205. doi: 10.1186/s13075-023-03184-7. Arthritis Res Ther. 2023. PMID: 37858143 Free PMC article.
Gender biases in Spanish rheumatology: Perception and facts.
Delgado Beltrán C, Castrejón I, Hernández-Cruz B, García Vivar ML, García de Vicuña R, Romera Baures M, Carreira P, Naredo E, Reina D, Galindo M, Peralta C, Varas de Dios B, Carmona L. Delgado Beltrán C, et al. Among authors: castrejon i. Reumatol Clin (Engl Ed). 2023 Aug-Sep;19(7):392-401. doi: 10.1016/j.reumae.2023.02.007. Epub 2023 May 8. Reumatol Clin (Engl Ed). 2023. PMID: 37164884 Free article.
Long-Term Survival of Subcutaneous Biosimilar Tumor Necrosis Factor Inhibitors Compared to Originators: Results From a Multicenter Prospective Registry.
Martínez-Vidal MP, Fernández-Carballido C, Otero-Varela L, Ruiz FJM, Pérez-Vera Y, Arija SM, Fernández CC, Jovaní V, Expósito L, Lario BÁ, García-González J, Sánchez-Alonso F, Castrejón I. Martínez-Vidal MP, et al. Among authors: castrejon i. J Rheumatol. 2024 Sep 1;51(9):877-883. doi: 10.3899/jrheum.2024-0001. J Rheumatol. 2024. PMID: 38825358 Free article.
Second and third TNF inhibitors in European patients with axial spondyloarthritis: effectiveness and impact of the reason for switching.
Linde L, Ørnbjerg LM, Heegaard Brahe C, Wallman JK, Di Giuseppe D, Závada J, Castrejon I, Díaz-Gonzalez F, Rotar Z, Tomšič M, Glintborg B, Gudbjornsson B, Geirsson AJ, Michelsen B, Kristianslund EK, Santos MJ, Barcelos A, Nordström D, Eklund KK, Ciurea A, Nissen M, Akar S, Hejl Hyldstrup L, Krogh NS, Hetland ML, Østergaard M. Linde L, et al. Among authors: castrejon i. Rheumatology (Oxford). 2024 Jul 1;63(7):1882-1892. doi: 10.1093/rheumatology/kead494. Rheumatology (Oxford). 2024. PMID: 37738257 Free PMC article.
Patient-reported outcomes in axial spondyloarthritis and psoriatic arthritis patients treated with secukinumab for 24 months in daily clinical practice.
Christiansen SN, Horskjær Rasmussen S, Pons M, Michelsen B, Glintborg B, Gudbjornsson B, Grondal G, Vencovsky J, Loft AG, Rotar Z, Pirkmajer KP, Nissen MJ, Baranová J, Macfarlane GJ, Jones GT, Iannone F, Caporali R, Laas K, Vorobjov S, Giuseppe DD, Olofsson T, Provan SA, Fagerli KM, Castrejon I, Otero-Varela L, van de Sande M, van der Horst-Bruinsma I, Nordström D, Kuusalo L, Bernardes M, Hetland ML, Østergaard M, Midtbøll Ørnbjerg L. Christiansen SN, et al. Among authors: castrejon i. Semin Arthritis Rheum. 2024 Apr;65:152388. doi: 10.1016/j.semarthrit.2024.152388. Epub 2024 Jan 26. Semin Arthritis Rheum. 2024. PMID: 38301349 Free article.
Effectiveness of secukinumab in radiographic and non-radiographic axial spondyloarthritis: a European routine-care observational study.
Christiansen SN, Horskjær Rasmussen S, Ostergaard M, Pons M, Michelsen B, Pavelka K, Codreanu C, Ciurea A, Glintborg B, Santos MJ, Sari I, Rotar Z, Gudbjornsson B, Macfarlane GJ, Relas H, Iannone F, Laas K, Wallman JK, van de Sande M, Provan SA, Castrejon I, Zavada J, Mogosan C, Nissen MJ, Loft AG, Barcelos A, Erez Y, Pirkmajer KP, Grondal G, Jones GT, Hokkanen AM, Chimenti MS, Vorobjov S, Di Giuseppe D, Kvien TK, Otero-Varela L, van der Horst-Bruinsma I, Hetland ML, Ørnbjerg LM. Christiansen SN, et al. Among authors: castrejon i. RMD Open. 2024 Jul 24;10(3):e004166. doi: 10.1136/rmdopen-2024-004166. RMD Open. 2024. PMID: 39053949 Free PMC article.
Four-year secukinumab treatment outcomes in European real-world patients with axial spondyloarthritis and psoriatic arthritis.
Pons M, Georgiadis S, Østergaard M, Ahmadzay ZF, Glintborg B, Heberg J, Christensen SN, Rasmussen S, Loft AG, Castrejón I, Sánchez-Alonso F, Iannone F, Nordström D, Hokkanen AM, Ciurea A, Nissen MJ, Závada J, Pavelka K, Rotar Z, Pirkmajer KP, Michelsen B, Mielnik P, Bernardes M, Khmelinskii N, Laas K, Vorobjov S, Codreanu C, Macfarlane GJ, Jones GT, Gudbjornsson B, Palsson O, Wallman JK, Horst-Bruinsma IV, Onen F, Hetland ML, Ørnbjerg LM. Pons M, et al. Among authors: castrejon i. Joint Bone Spine. 2024 Nov 26:105824. doi: 10.1016/j.jbspin.2024.105824. Online ahead of print. Joint Bone Spine. 2024. PMID: 39608666 Free article.
Correction: Factors associated with discontinuation of biologics in patients with inflammatory arthritis in remission: data from the BIOBADASER registry.
Valero M, Sanchez-Piedra C, Freire M, Colazo M, Busquets N, Merino-Ibarra E, Rodriguez-Lozano C, Manrique S, Campos C, Sanchez-Alonso F, Castrejon I. Valero M, et al. Among authors: castrejon i. Arthritis Res Ther. 2023 Oct 25;25(1):210. doi: 10.1186/s13075-023-03194-5. Arthritis Res Ther. 2023. PMID: 37880797 Free PMC article. No abstract available.
Cancer risk with biologic and targeted synthetic DMARDs in patients with rheumatic diseases and previous malignancies: Results from the BIOBADASER register.
Molina-Collada J, Alonso F, Otero L, Bohórquez C, Díaz Torné C, Pérez García C, Blanco Madrigal JM, Vela P, Álvaro-Gracia JM, Castrejón I; BIOBADASER group. Molina-Collada J, et al. Among authors: castrejon i. Semin Arthritis Rheum. 2024 Feb;64:152341. doi: 10.1016/j.semarthrit.2023.152341. Epub 2023 Dec 9. Semin Arthritis Rheum. 2024. PMID: 38128174
131 results